CVKD Cadrenal Therapeutics, Inc.
$0.97
Cadrenal Therapeutics, Inc. (CVKD) Earnings News
Earnings press releases, previews and reviews for Cadrenal Therapeutics, Inc. (CVKD), newest first.
Thursday
August 13, 2026
4:15 PM ET
Cadrenal Therapeutics Reports Second Quarter 2026 Financial Results; Provides a Corporate Update on the Cardiac Acute Critical Care Franchise and the Strategic Partnering Process
Thursday
May 7, 2026
8:30 AM ET
Cadrenal Therapeutics Reports First Quarter 2026 Financial Results and Provides Phase 3 Development Update on CAD-1005 Following End-of-Phase 2 Meeting with FDA